Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050055057 A1
Publication typeApplication
Application numberUS 10/654,959
Publication date10 Mar 2005
Filing date5 Sep 2003
Priority date5 Sep 2003
Also published asUS8744558, US20070191893
Publication number10654959, 654959, US 2005/0055057 A1, US 2005/055057 A1, US 20050055057 A1, US 20050055057A1, US 2005055057 A1, US 2005055057A1, US-A1-20050055057, US-A1-2005055057, US2005/0055057A1, US2005/055057A1, US20050055057 A1, US20050055057A1, US2005055057 A1, US2005055057A1
InventorsMorton Mower
Original AssigneeMirowski Famliy Ventures, L.L.C.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method and apparatus for providing ipselateral therapy
US 20050055057 A1
Abstract
Methods, apparatus, and systems are provided to control contraction of the heart. At least one sensing element receives signals indicating electrical activity of sinus rhythm of the heart. The electrical activity is monitored and analyzed to detect an event. In addition, the electrical activity is monitored to detect, for example, premature stimulation and contraction of a portion of the heart, such as the left ventricle. Contraction in the pre-excited portion of the heart is then suppressed using, for example, one or more anodal electrical pulses. The heart may then be allowed to contract naturally, or a stimulating pulse may be applied to assist the heart in contracting.
Images(6)
Previous page
Next page
Claims(41)
1. A method of controlling contraction of a heart, comprising:
receiving signals indicating electrical activity of sinus rhythm at a portion of the heart;
detecting an event in the electrical activity at the portion of the heart;
detecting when the electrical activity at an additional portion of the heart reaches a threshold within a predetermined period of time of the event; and
suppressing contraction in the additional portion of the heart based on when the electrical activity reaches the threshold.
2. The method of claim 1, wherein receiving signals indicating electrical activity comprises sensing depolarization signals originating from an atrium.
3. The method of claim 2, wherein suppressing contraction of the additional portion of the heart comprises suppressing contraction of a ventricle.
4. The method of claim 2, wherein sensing depolarization signals comprises sensing depolarization signals from both the left atrium and the right atrium.
5. The method of claim 1, wherein detecting an event in the electrical activity comprises detecting a P-wave in an electrocardiagram signal of the heart.
6. The method of claim 1, wherein suppressing contraction in the additional portion of the heart comprises applying, to the portion of the heart, at least one pulse that repolarizes the additional portion of the heart to a voltage less than a threshold sufficient for contraction.
7. The method of claim 6, wherein applying the voltage comprises applying at least one anodal pulse.
8. The method of claim 1, further comprising:
applying a pulse to stimulate contraction in the additional portion of the heart after suppressing contraction.
9. The method of claim 8, wherein applying the pulse to stimulate contraction comprises applying the pulse to stimulate contraction in a ventricle.
10. An apparatus for controlling contraction of a heart, comprising:
means for receiving signals indicating electrical activity of sinus rhythm at a portion of the heart;
means for detecting an event in the electrical activity at the portion of the heart;
means for detecting when the electrical activity at an additional portion of the heart reaches a threshold within a predetermined period of time of the event; and
means for suppressing contraction in the additional portion of the heart based on when the electrical activity reaches the threshold.
11. A system for controlling contraction of a heart, comprising:
at least one sensing element configured to receive signals indicating electrical activity of sinus rhythm of the heart;
a processor coupled to the at least one sensing element, configured to detect an event in the electrical activity, and provide a control signal based on when the electrical activity reaches a threshold within a predetermined period of time of the event; and
a signal generator, coupled to the processor, to provide an electrical signal suppressing contraction in a portion of the heart responsive to the control signal.
12. The system of claim 11, wherein the signal generator comprises a pulse generator configured to generate at least one pulse that repolarizes the portion of the heart to a voltage less than a threshold sufficient for contraction.
13. The system of claim 12, wherein the pulse generator is further configured to generate at least one pulse to stimulate contraction of the portion of the heart after suppressing contraction.
14. A method for controlling contraction of a heart, comprising:
receiving signals indicating electrical activity of sinus rhythm from a portion of the heart;
detecting an event in the electrical activity; and
suppressing contraction in an additional portion of the heart for a predetermined period of time from the detected event.
15. The method of claim 14, further comprising:
stimulating contraction in the at least one additional portion of the heart subsequent to suppressing contraction.
16. The method of claim 14, wherein receiving signals indicating electrical activity comprises sensing depolarization signals originating from an atrium.
17. The method of claim 16, wherein sensing depolarization signals comprises sensing depolarization signals from both the left atrium and the right atrium.
18. The method of claim 14, wherein suppressing contraction in the additional portion of the heart comprises suppressing contraction of a ventricle.
19. The method of claim 14, wherein detecting an event in the electrical activity comprises detecting a P-wave in an electrocardiogram signal of the heart.
20. The method of claim 14, wherein suppressing contraction in the additional portion of the heart comprises applying, to the additional portion of the heart, at least one pulse that repolarizes the additional portion of the heart to a voltage less than a threshold sufficient for contraction.
21. The method of claim 20, wherein applying the voltage comprises applying at least one anodal pulse.
22. The method of claim 14, further comprising:
applying a pulse to stimulate contraction in the additional portion of the heart after suppressing contraction.
23. The method of claim 22, wherein applying the pulse to stimulate contraction comprises applying the pulse to stimulate contraction in a ventricle.
24. An apparatus for controlling contraction of a heart, comprising:
means for receiving signals indicating electrical activity of sinus rhythm from a portion of the heart;
means for detecting an event in the electrical activity; and
means for suppressing contraction in an additional portion of the heart for a predetermined period of time from the detected event.
25. The apparatus of claim 24, further comprising:
means for stimulating contraction in the additional portion of the heart after suppressing contraction.
26. A system for controlling contraction of a heart, comprising:
at least one sensing element configured to receive signals indicating electrical activity of sinus rhythm from at least a portion of the heart;
a processor coupled to the at least one sensing element, configured to detect an event in the electrical activity, and provide a control signal in response to the detected event; and
a signal generator configured to provide an electrical signal to suppress contraction in an additional portion of the heart for a predetermined period of time from the event in response to the control signal.
27. The system of claim 26, wherein the signal generator is configured to provide a stimulating electrical signal to stimulate contraction in the additional portion of the heart.
28. The system of claim 26, further comprising a stimulator configured to provide at least one stimulating electrical pulse to stimulate contraction in the at least one additional portion of the heart.
29. A method of controlling contraction of a heart, comprising:
receiving signals indicating electrical activity of sinus rhythm from the heart;
suppressing premature contraction of a first chamber of the heart;
detecting when electrical activity at a second chamber of the heart reaches a threshold; and
ceasing the suppression of contraction of the first chamber of the heart based on when the electrical activity at the second chamber of the heart reaches the threshold.
30. The method of claim 29, wherein receiving the signals indicating electrical activity comprises sensing depolarization signals originating from a ventricle of the heart.
31. The method of claim 30, wherein suppressing contraction of the first chamber of the heart comprises suppressing contraction of a ventricle.
32. The method of claim 29, wherein suppressing contraction in the first chamber of the heart comprises applying, to the first chamber, at least one pulse that repolarizes at least a portion of the first chamber to a voltage less than a threshold sufficient for contraction.
33. The method of claim 32, wherein applying the voltage comprises applying at least one anodal pulse.
34. The method of claim 29, further comprising stimulating contraction of the first chamber of the heart when the electrical activity at the second chamber of the heart reaches the threshold.
35. The method of claim 29, wherein suppressing contraction of the first chamber of the heart comprises suppressing contraction of a left ventricle of the heart.
36. The method of claim 35, wherein detecting when the electrical activity at the second chamber reaches the threshold comprises detecting when the electrical activity at a right ventricle of the heart reaches the threshold.
37. The method of claim 36, wherein ceasing the suppression of contraction of the first chamber of the heart comprises allowing the left ventricle to contract.
38. An apparatus for controlling contraction of a heart, comprising:
means for receiving signals indicating electrical activity of sinus rhythm from the heart;
means for suppressing contraction of a first chamber of the heart based on the received signals;
means for detecting when electrical activity at a second chamber of the heart reaches a threshold based on the received signals; and
means for ceasing the suppression of contraction of the first chamber of the heart based on when the electrical activity at the second chamber of the heart reaches the threshold.
39. A system for controlling contraction of a heart, comprising:
at least one sensing element configured to receive signals indicating electrical activity of sinus rhythm of the heart;
a processor coupled to the at least one sensing element, configured to determine when a first chamber of the heart is contracting, and provide a control signal based on when the electrical activity of a second chamber of the heart reaches a threshold; and
a signal generator, coupled to the processor, to selectively provide an electrical signal suppressing contraction in the first chamber of the heart responsive to the control signal.
40. The system of claim 39, wherein the signal generator comprises a pulse generator configured to generate at least one pulse that repolarizes at least a portion of the first chamber of the heart to a voltage less than a threshold sufficient for contraction.
41. The system of claim 40, wherein the pulse generator is further configured to generate at least one pulse to stimulate contraction of the first chamber of the heart in response to the control signal.
Description
    DESCRIPTION OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    The present invention relates to medical devices, and in particular, to methods, devices, and systems for controlling contraction of a heart.
  • [0003]
    2. Background
  • [0004]
    During a normal heart beat, the heart contracts in a coordinated fashion to pump blood. In particular, the heart contracts based on rhythmic electrical impulses, which are spread over the heart using specialized fibers. These rhythmic electrical pulses are initiated by the heart's natural pacemaker called the sino-atrial node (SA node). In a normal heart there is a main pathway for the electrical current, which passes from the upper part of the heart (the atria) to the lower part (the ventricles). First, the SA node initiates electrical impulses to cause the right and left atria to contract. As the atria contract, the electrical impulses from the SA node propagate to the atrial-ventricular node (“AV node”). The time these impulses take to propagate from the SA node through the AV node is known as the A-V delay. The A-V delay allows the atria to fully contract and fill the ventricles with blood. The AV node then transmits a second impulse, which causes contraction in the right and left ventricles. Blood from the ventricles then flows out of the heart and to the rest of the body. Therefore, the heart relies upon a rhythmic cycle of electrical impulses to pump blood efficiently.
  • [0005]
    A heart, however, may have cardiac defects that interfere with the rhythmic cycle or conduction of electrical impulses. For example, there are types of cardiac deficiencies that cause early stimulation and contraction in the heart. Such pre-excitation deficiencies exist, for example, where the ventricles are activated by the impulse originating from the atrium at a time earlier than would be expected if the impulse reached the ventricles by way of the normal conduction system described above. For example, the Wolff-Parkinson-White syndrome is characterized by early stimulation and contraction of the ventricles. In Wolff-Parkinson-White syndrome, there is an accessory conducting pathway that leads from the atria to the ventricles. This pathway may at times encourage a rapid rhythm. In particular, instead of allowing the next heart beat to begin at the SA node, the extra pathway can pick up an electrical impulse in the ventricles and send it back upward to the atria. When this happens, the impulse begins to travel abnormally in a rapid, circular manner, causing a rapid heart rate.
  • [0006]
    As noted above, a normal heartbeat includes an optimum A-V delay period to allow the atria to fully contract and fill the ventricles with blood. Cardiac defects, such as Wolff-Parkinson-White, cause early stimulation and contraction of the ventricles before the end of the A-V delay period, and thus, decrease the efficiency of the heart and may lead to heart failure.
  • [0007]
    Unfortunately, known stimulation devices, such as artificial pacemakers, cannot compensate for such early stimulation in the heart. While Wolff-Parkinson-White syndrome may be controlled by certain drugs or through a procedure known as catheter ablation, known implantable devices only apply stimulating pulses to assist contraction in the heart and are unable to compensate for early stimulation, such as in Wolff-Parkinson-White syndrome. Accordingly, it would be desirable to provide methods, apparatus, and systems, which can overcome these and other deficiencies in the prior art, for example, to assist the heart in contracting in a coordinated fashion.
  • SUMMARY OF THE INVENTION
  • [0008]
    In accordance with an aspect of the present invention, methods and apparatus are provided for controlling contraction of a heart. Signals indicating electrical activity of sinus rhythm at a portion of the heart are received. An event is detected in the electrical activity at the portion of the heart. When the electrical activity at an additional portion of the heart reaches a threshold within a predetermined period of time of the event, contraction is suppressed in the additional portion of the heart based on when the electrical activity reaches the threshold.
  • [0009]
    In accordance with another aspect of the present invention, a system controls contraction of a heart. At least one sensing element is configured to receive signals indicating electrical activity of sinus rhythm from the heart. A processor is coupled to the at least one sensing element and configured to detect an event in the electrical activity. The processor provides a control signal based on when the electrical activity reaches a threshold within a predetermined period of time of the event. A signal generator is coupled to the processor and provides an electrical signal suppressing contraction in a portion of the heart responsive to the control signal.
  • [0010]
    In accordance with another aspect of the present invention, methods and apparatus are provided for controlling contraction of a heart. Signals indicating electrical activity of sinus rhythm at a portion of the heart are received. An event is detected in the electrical activity. Contraction is then suppressed in the additional portion of the heart for a predetermined period of time from the detected event.
  • [0011]
    In accordance with another aspect of the present invention, a system controls contraction of a heart. At least one sensing element is configured to receive signals indicating electrical activity of sinus rhythm from at least a portion of the heart. A processor is coupled to the at least one sensing element and configured to detect an event in the electrical activity. The processor provides a control signal in response to the detected event. A signal generator is configured to then provide an electrical signal to suppress contraction in an additional portion of the heart for a predetermined period of time from the event in response to the control signal.
  • [0012]
    In accordance with another aspect of the present invention, methods and apparatus are provided for controlling contraction of a heart. Signals that indicate electrical activity of sinus rhythm are received from the heart. Contraction of a first chamber of the heart is suppressed based on the received signals. When the electrical activity at a second chamber of the heart reaches a threshold, the suppression of contraction of the first chamber ceases.
  • [0013]
    In accordance with another aspect of the present invention, a system controls contraction of a heart. At least one sensing element is configured to receive signals indicating electrical activity of sinus rhythm of the heart. A processor is coupled to the at least one sensing element. The processor is configured to determine when a first chamber of the heart is contracting, and provides a control signal based on when the electrical activity of a second chamber of the heart reaches a threshold. A signal generator is coupled to the processor and selectively provides an electrical signal that suppresses contraction in the first chamber of the heart in response to the control signal.
  • [0014]
    Additional features and advantages of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The features and advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
  • [0015]
    It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0016]
    The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description, serve to explain the principles of the invention.
  • [0017]
    In the figures:
  • [0018]
    FIG. 1 illustrates an environment in which methods, apparatus, and systems may be applied consistent with the principles of the present invention;
  • [0019]
    FIG. 2A illustrates electrical activity of sinus rhythm associated with a normal heartbeat;
  • [0020]
    FIG. 2B illustrates electrical activity of sinus rhythm associated with a heart suffering from Wolff-Parkinson-White syndrome;
  • [0021]
    FIG. 3 illustrates a functional block diagram of a controller for controlling contraction of a heart consistent with the principles of the present invention;
  • [0022]
    FIG. 4 illustrates a method of controlling contraction of a heart consistent with the principles of the present invention; and
  • [0023]
    FIG. 5 illustrates another method of controlling contraction of a heart consistent with the principles of the present invention.
  • DESCRIPTION OF THE EMBODIMENTS
  • [0024]
    Methods, apparatus, and systems are provided to control contraction of the heart. At least one sensing element receives signals indicating electrical activity of sinus rhythm of the heart. The electrical activity is monitored and analyzed to detect an event. In addition, the electrical activity is monitored to detect when the electrical activity reaches a threshold within a predetermined period of time from the event. Contraction in the heart is then suppressed using, for example, one or more electrical pulses. In addition, after another predetermined period of time, the heart may then be allowed to contract naturally, or a stimulating pulse may be applied to assist the heart in contracting.
  • [0025]
    Reference will now be made in detail to exemplary embodiments of the invention, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
  • [0026]
    FIG. 1 illustrates an environment in which methods, apparatus, and systems may be applied consistent with the principles of the present invention. As shown, a controller 104 may accompany a heart 102. In addition, heart 102 is shown with a superior vena cava 106, a right atrium 108, a left atrium 110, a right ventricle 112, a left ventricle 114, a sino-atrial node (“SA node”) 116, an atrial-ventricular node (“AV node”) 118, a Bundle of His 120, a right bundle branch 122, a left bundle branch 124, and Purkinje fibers 126.
  • [0027]
    Heart 102 normally contracts in two stages based on sinus rhythm. Sinus rhythm is where heart 102 contracts in response to electrical impulses generated from SA node 116. In order to cause contraction in the cardiac muscle of heart 102, the electrical impulses from SA node 116 must depolarize the muscle fibers above a threshold voltage of approximately −80 mV.
  • [0028]
    Accordingly, as the electrical impulses propagate from SA node 116 to AV node 118, right atrium 108 and left atrium 110 contract. Typically, the electrical impulses take approximately 120 to 200 milliseconds to travel from SA node 116 to AV node 118 (i.e., an AV delay of 120 to 200 milliseconds) and allow right ventricle 112 and left ventricle 114 to fill with blood.
  • [0029]
    Once the electrical impulses propagate to AV node 118, AV node 118 then emits an electrical impulse. This electrical impulse propagates relatively quickly over heart 102 down Bundle of His 120, and over right bundle branch 122, left bundle branch 124, and Purkinje fibers 126. In response, cardiac muscles in right ventricle 112 and left ventricle 114 depolarize and contract to pump blood to the rest of the body (not shown).
  • [0030]
    Controller 104 assists heart 102 to contract in a coordinated fashion. For example, controller 104 may apply one or more electrical pulses that suppress or stimulate contraction in the cardiac muscle of heart 102 as needed. As noted above, in order to contract, cardiac muscle in heart 102 must be depolarized above a threshold voltage of approximately −80 mV. In addition, when recovering from contraction, the cardiac muscle repolarizes to a resting voltage of approximately −90 mV. Thus, controller 104 may selectively suppress or stimulate contraction in heart 102 by applying electrical pulses to repolarize or depolarize the cardiac muscle. In general, cathodal electrical pulses tend to stimulate contraction while anodal electrical pulses tend to suppress contraction.
  • [0031]
    Controller 104 may be coupled to heart 102 using a lead 128. Lead 128 may be installed endocardially into heart 102 via superior vena cava 106 using known surgical procedures. Lead 128 may be implemented as a hollow catheter made of an insulating material, such as silicone rubber, and provide a plurality of connection paths for carrying signals representing electrical activity of heart 102 and carrying electrical signals, such as electrical pulses, from controller 104. For example, lead 128 may further include an atrial lead branch 130, an atrial electrode 132, a right ventricle lead branch 134, a right ventricle electrode 136, a left ventricle lead branch 138, and a left ventricle electrode 140. Alternatively, controller 104 may be coupled to heart 102 using a plurality of leads. The leads may be endocardial, epicardial, or subcutaneous.
  • [0032]
    Atrial lead branch 130 provides a connection path between controller 104 and right atrium 108 for carrying signals associated with right atrium 108 and SA node 116 and electrical signals from controller 104. Although atrial lead branch 130 is shown integrated within lead 128, atrial lead branch 130 may also be implemented using a separate lead from controller 104.
  • [0033]
    Atrial electrode 132 senses electrical activity in heart 102 associated with right atrium 108 and SA node 116 and delivers electrical signals from controller 104. Atrial electrode 132 may be implemented, for example, as a helical coil of wire made of a metal, such as stainless steel. Although a single electrode is shown, a plurality of electrodes may be implemented with atrial electrode 132.
  • [0034]
    Right ventricle lead branch 132 provides a connection path for carrying signals associated with right ventricle 112 and providing electrical signals from controller 104 to right ventricle 112. Although right ventricle lead branch 134 is shown integrated within lead 128, right ventricle lead branch 134 may also be implemented using a separate lead from controller 104.
  • [0035]
    Right ventricle electrode 136 senses electrical activity in heart 102 associated with right ventricle 112, such as electrical impulses from AV node 118 and propagating over right bundle branch 122. Right ventricle electrode 136 may also be implemented, for example, as a helical coil of wire made of a metal, such as stainless steel. In addition, a plurality of electrodes may be implemented with right ventricle electrode 136.
  • [0036]
    Left ventricle lead branch 138 provides a connection path for carrying signals associated with left ventricle 114 and providing electrical signals from controller 104 to left ventricle 114. Although left ventricle lead branch 138 is shown integrated within lead 128, left ventricle lead branch 138 may also be implemented using a separate lead from controller 104.
  • [0037]
    Left ventricle electrode 140 senses electrical activity in heart 102 associated with left ventricle 114, such as electrical impulses from AV node 118 and propagating over left bundle branch 124. Left ventricle electrode 140 may also be implemented, for example, as a helical coil of wire made of a metal, such as stainless steel. In addition, a plurality of electrodes may be implemented with left ventricle electrode 140.
  • [0038]
    FIG. 2A illustrates electrical activity of sinus rhythm associated with a normal heartbeat. A waveform 200 shows one cycle of sinus rhythm and comprises a plurality of events including a P-wave 202, a QRS complex 204, and a T-wave 206. P-wave 202 indicates electrical activity that coincides with the spread of electrical impulses from SA node 116 over right atrium 108 and left atrium 110 and the contraction of these chambers. Typically, P-wave 202 has an amplitude of 0.1 mV and a duration of approximately 0.1 seconds.
  • [0039]
    QRS complex 204 indicates electrical activity that coincides with the spread of electrical impulses over right ventricle 112 and left ventricle 114 and the contraction of these chambers. Typically, QRS complex 204 occurs approximately 0.2 seconds after P-wave 202. In addition, QRS complex 204 typically has an amplitude of approximately 1 mV and a duration of approximately 0.08 seconds.
  • [0040]
    T-wave 206 indicates electrical activity that coincides with the recovery of right ventricle 112 and left ventricle 114 from contraction. Typically, T-wave 206 occurs approximately 0.2 seconds after QRS complex 204. In addition, T-wave typically has an amplitude and duration twice that of P-wave 202, i.e., approximately 0.2 mV and 0.2 seconds.
  • [0041]
    FIG. 2B illustrates electrical activity of sinus rhythm associated with a heart suffering from Wolff-Parkinson-White syndrome. Similar to waveform 200, a waveform 208 comprises P-wave 202, QRS complex 204, and T-wave 206. However, due to Wolff-Parkinson-White syndrome, waveform 208 also shows a region of premature electrical activity 210 between P-wave 202 and QRS complex 204. Premature electrical activity 210 may, for example, cause premature stimulation and contraction of right ventricle 112 and/or left ventricle 114. Although Wolff-Parkinson-White syndrome is illustrated in FIG. 2B, other types of cardiac defects, such as other types of pre-excitation defects, may be treated in accordance with the principles of the present invention.
  • [0042]
    FIG. 3 illustrates a functional block diagram of controller 104 for controlling contraction of heart 102 consistent with the principles of the present invention. As shown, controller 104 includes sense amplifiers 300, 302, and 304, a processor 306, a memory 308, a telemetry module 310, and a signal generator 312.
  • [0043]
    Sense amplifiers 300, 302, and 304 are coupled to atrial electrode 132, right ventricle electrode 136, and left ventricle electrode 140. Sense amplifiers 300, 302, and 304 receive signals indicating electrical activity of heart 102 from their respective electrodes, amplify these signals, and provide them to processor 306. Sense amplifiers 300, 302, and 304 may be implemented using, for example, well known circuitry.
  • [0044]
    Processor 306 receives and monitors signals from sense amplifiers 300, 302, and 304 and generates a control signal. For example, in order to treat Wolff-Parkinson-White syndrome, processor 306 may monitor the signals from sense amplifiers 300, 302, and 304 to detect when the electrical activity of heart 102 indicates premature stimulation of a ventricle, such as from premature electrical activity 210. Processor 306 may detect the possibility of premature contraction of a portion of the heart based on a variety of parameters. For example, processor 306 may monitor the electrical activity of heart 102 during sinus rhythm and detect when the electrical activity in a ventricle reaches a threshold level, such as 0.07 mV or 0.1 mV, within a predetermined period of time, such as 0.1 seconds, from P-wave 202. Processor 306 preferably detects premature contraction in a ventricle or atrium before the ventricle or atrium receives a level of stimulation after which suppression of contraction could not occur. The threshold level may be modified as required to ensure that the detection of premature stimulation occurs in time to suppress contraction. Processor 306 may use other parameters and values consistent with the principles of the present invention to detect pre-excitation of a ventricle or atrium. For example, processor 306 may detect premature stimulation based on detecting electrical activity in a portion of heart 102, detecting contraction of a portion of heart 102, detecting a rise in blood pressure, or detecting a change in impedance in a portion of heart 102. Processor 306 then provides a control signal to signal generator 312 based on the electrical activity of heart 102.
  • [0045]
    Alternatively, processor 306 may be configured to provide the control signal to signal generator 312 automatically. For example, processor 306 may be configured to provide the control signal to signal generator 312 automatically upon detecting P-wave 202.
  • [0046]
    Processor 306 may be implemented using known devices. For example, processor 306 may be implemented using a series of digital circuits. Alternatively, processor 306 may be implemented using a microprocessor, such as those manufactured by Intel Corporation.
  • [0047]
    Memory 308 provides storage for information used by processor 306. For example, memory 308 may include instructions for configuring processor 306 and instructions for monitoring the electrical activity of heart 102. Memory 308 may be implemented using known types of memory, such as a random access memory and read-only memory.
  • [0048]
    Telemetry module 310 provides diagnostic information indicating the performance of controller 104. For example, telemetry module 310 may transmit the signals received from sense amplifiers 300, 302, and 304, and signals generated by signal generator 312 via a radio link to another device, such as an external programmer (not shown). Telemetry module 310 may also collect and transmit other types of information. Telemetry module 310 may be implemented as a radio receiver/transmitter using a known radio frequency, such as 100 kHz.
  • [0049]
    Signal generator 312 generates electrical pulses for treating heart 102 via lead 128. Signal generator 312 may direct electrical pulses to one or more sites in heart 102, such as in right ventricle 112 or left ventricle 114 respectively via right ventricle lead branch 134 and left ventricle lead branch 138. In addition, as noted above, lead 128 may include a plurality of electrodes at various sites in each chamber of heart 102. Accordingly, signal generator 312 may also direct electrical pulses to one or more specific sites in each chamber of heart 102. Furthermore, signal generator 312 may be coupled to heart 102 via a plurality of leads in addition to lead 128.
  • [0050]
    Signal generator 312 may generate one or more electrical pulses to suppress contraction in heart 102 and compensate for premature stimulation, such as from premature electrical activity 210. In particular, signal generator 312 may generate an anodal electrical pulse of approximately 5 volts and with a duration of approximately 2-4 milliseconds to suppress contraction in heart 102. However, signal generator 312 may use other types of pulses, such as biphasic pulses, which can also be configured to suppress contraction in heart 102. For example, signal generator 312 could use pulses of the type disclosed in U.S. Pat. No. 5,871,506, entitled “AUGMENTATION OF ELECTRICAL CONDUCTION AND CONTRACTILITY BY BIPHASIC CARDIAC PACING,” U.S. Pat. No. 6,067,470, entitled “SYSTEM AND METHOD FOR MULTIPLE SITE BIPHASIC STIMULATION TO REVERT VENTRICULAR ARRHYTHMIAS”, U.S. Pat. No. 6,411,845, entitled “SYSTEM AND METHOD FOR MULTIPLE SITE BIPHASIC STIMULATION TO REVERT VENTRICULAR ARRHYTHMIAS,” U.S. Pat. No. 6,141,587, entitled “AUGMENTATION OF MUSCLE CONTRACTILITY BY BIPHASIC STIMULATION,” U.S. Pat. No. 6,136,019, entitled “AUGMENTATION OF ELECTRICAL CONDUCTION AND CONTRACTILITY BY BIPHASIC CARDIAC PACING ADMINISTERED VIA THE CARDIAC BLOOD POOL,” U.S. Pat. No. 6,141,586, entitled “METHOD AND APPARATUS TO ALLOW CYCLIC PACING AT AN AVERAGE RATE JUST ABOVE THE INTRINSIC HEART RATE SO AS TO MAXIMIZE INOTROPIC PACING EFFECTS AT MINIMAL HEART RATES,” U.S. Patent No. 6,178,351, entitled “ATRIAL SENSING AND MULTIPLE SITE STIMULATION AS INTERVENTION MEANS FOR ATRIAL FIBRILLATION,” U.S. Pat. No. 6,343,232, entitled “AUGMENTATION OF MUSCLE CONTRACTILITY BY BIPHASIC STIMULATION,” U.S. Pat. No. 6,341,235, entitled AUGMENTATION OF ELECTRICAL CONDUCTION AND CONTRACTILITY BY BIPHASIC CARDIAC PACING VIA THE CARDIAC BLOOD POOL,” U.S. Pat. No. 6,337,995, entitled “ATRIAL SENSING AND MULTIPLE SITE STIMULATION FOR ATRIAL FIBRILLATION,” U.S. Pat. No. 6,332,096, entitled “AUGMENTATION OF ELECTRICAL CONDUCTION AND CONTRACTILITY BY BIPHASIC CARDIAC PACING,” and U.S. Pat. No. 6,295,470, entitled “ANTITACHYCARDIAL PACING,” all incorporated herein by reference.
  • [0051]
    In addition, signal generator 312 may vary the electrical pulses delivered to heart 102 to control the suppression of contraction. Signal generator 312 may vary the number of pulses, the pulse amplitude, and pulse width. For example, signal generator 312 may generate multiple pulses to suppress contraction in heart 102 for a longer period of time than if a single pulse were used. Alternatively, signal generator 312 may increase pulse amplitude and duration to increase the period of time contraction is suppressed in heart 102.
  • [0052]
    After one or more suppression pulses from signal generator 312 are applied to the pre-excited area of heart 102 (e.g., left ventricle 114) additional suppression pulses may be applied if necessary. For example, processor 306 may determine that the right ventricle will not contract until after a standard A-V delay period causing signal generator 312 to continue to suppress contraction, for example, of left ventricle 114 until such contraction can be coordinated with contraction of right ventricle 112. For example, the present invention may allow for delay of contraction of left ventricle 114 for as much as 40 milliseconds to allow right ventricle 112 and left ventricle 114 to contract in a coordinated manner, thereby improving the hemodynamic efficiency of heart 102. In addition, if the one or more suppression pulses from signal generator 312 would cause a longer delay than desired for optimum coordinated contraction of heart 102, signal generator 312 may apply one or more stimulation pulses following the application of the one or more suppression pulses. The present invention may also be used to treat premature contraction of right ventricle 112, right atrium 108, left atrium 110, or any desired combination of chambers. For example, signal generator 312 may apply one or more pulses that suppress contraction in right ventricle 112 in order to delay the contraction of right ventricle 112 and allow right ventricle 112 to contract in a coordinated manner with left ventricle 114.
  • [0053]
    Furthermore, signal generator 312 may be configured to provide one or more electrical pulses to stimulate contraction in heart 102. For example, signal generator 312 may provide a cathodal pulse of 5 V for a duration of approximately 2 milliseconds to stimulate contraction in heart 102. Signal generator 312 may use other types of pulses, such as biphasic pulses or anodal pulses, to stimulate or suppress contraction in heart 102.
  • [0054]
    FIG. 4 illustrates a method of controlling contraction of a heart consistent with the principles of the present invention. In stage 400, controller 104 receives signals indicating electrical activity of heart 102. For example, atrial electrode 132, right ventricle electrode 136, and left ventricle electrode 140 may provide signals to sense amplifiers 300, 302, and 304, respectively. Sense amplifiers 300, 302, and 304 may then amplify these signals and provide them to processor 306. Processor 306 may then interpret these signals to determine the electrical activity of sinus rhythm for heart 102. In addition, processor 306 may store data from these signals in memory 306, for example, for transmission by telemetry module 310 to another device.
  • [0055]
    In stage 402, processor 306 detects an event in the electrical activity. For example, processor 306 may monitor the electrical activity for P-wave 202. In addition, processor 306 may store information related to this event, such as time and amplitude of the event, in memory 308.
  • [0056]
    In stage 404, processor 306 then detects whether the electrical activity exceeds a threshold, such as 0.07 or 0.1 mV, within a predetermined period of time, such as 0.1 seconds, from the event. If the electrical activity does not exceed the threshold within the predetermined period of time, processor 306 interprets this circumstance as a normal sinus rhythm and processing repeats at stage 400. However, if processor 306 detects that the electrical activity reaches the threshold within the predetermined period of time, then processor 306 may interpret this circumstance as premature stimulation in an area of heart 102, such as premature electrical activity 210 in left ventricle 114 and/or right ventricle 112.
  • [0057]
    In stage 406, processor 306 provides a control signal to signal generator 312 to suppress contraction in heart 102. The control signal may specify specific sites in heart 102 and the type of electrical pulses used to suppress contraction. For example, processor 306 may provide a control signal specifying either right ventricle 112, or left ventricle 114, or both. In addition, processor 306 may specify a pulse type, such as cathodal, anodal, or biphasic, a pulse width, and a pulse amplitude.
  • [0058]
    In stage 406, in response to the control signal from processor 306, signal generator 312 applies one or more electrical pulses to heart 102 via lead 128. For example, signal generator 312 may send electrical pulses via lead 128 to right ventricle electrode 136 and/or left ventricle electrode 140.
  • [0059]
    In stage 408, signal generator 312 completes the application of the electrical pulses suppressing contraction. Processor 306 may then monitor the electrical activity of heart 102 to determine its response and whether the electrical pulses were sufficient to compensate for the premature stimulation, for example, by premature electrical activity 210. If needed, based on the response of heart 102, processor 306 may direct signal generator 312 to apply additional electrical pulses to suppress contraction for an additional period of time. Upon completion of the suppressing electrical pulses, processor 306 may allow heart 102 to contract naturally. Alternatively, processor 306 may provide a control signal to signal generator 312 to subsequently stimulate one or more sites to assist contraction in heart 102. Processing then repeats again at stage 400.
  • [0060]
    FIG. 5 illustrates another method of controlling contraction of a heart consistent with the principles of the present invention. In stage 500, controller 104 receives signals indicating electrical activity of heart 102. For example, atrial electrode 132, right ventricle electrode 136, and left ventricle electrode 140 may provide signals to sense amplifiers 300, 302, and 304, respectively. Sense amplifiers 300, 302, and 304 may then amplify these signals and provide them to processor 306. Processor 306 may then interpret these signals to determine the electrical activity of sinus rhythm for heart 102. In addition, processor 306 may store data from these signals in memory 306, for example, for transmission by telemetry module 310 to another device.
  • [0061]
    In stage 502, processor 306 determines whether suppression is required in one or more portions of heart 102 based on the received signals. For example, processor 306 may monitor the electrical activity of right ventricle 112 and left ventricle 114 and determine whether either ventricle will prematurely contract. Processor 306 may store information related to this premature contraction, such as the time and amplitude, in memory 308.
  • [0062]
    Processor 306 may determine whether a chamber of heart 102, such as right ventricle 112 or left ventricle 114, will prematurely contract based on whether the electrical activity in that chamber exceeds a threshold, such as 0.07 or 0.1 mV, within a predetermined period of time of contraction of another chamber of the heart, such as the right atrium. If the electrical activity does not exceed the threshold within the predetermined period of time, processor 306 may interpret this circumstance as a normal sinus rhythm and processing repeats again at stage 500. However, if processor 306 detects that the electrical activity reaches the threshold within the predetermined period of time, processor 306 may interpret this circumstance as premature stimulation in portion of heart 102, such as premature electrical activity 210 in left ventricle 114 and/or right ventricle 112. Processing may then flow to stage 504.
  • [0063]
    Alternatively, processor 306 may determine whether a first chamber of heart 102, such as right ventricle 112, will prematurely contract based on whether the electrical activity in that chamber exceeds a threshold, such as 0.07 or 0.1 mV, prior to electrical activity in a second chamber, such as left ventricle 114, exceeding a threshold, such as 0.07 or 0.1 mV. If the respective electrical activity in the first and second chambers indicates coordinated contraction, processor 306 may interpret this circumstance as a normal sinus rhythm and processing repeats again at stage 500. However, if processor 306 detects that the timing of the electrical activity in the first chamber will cause uncoordinated contraction relative to the second chamber, processor 306 may interpret this circumstance as premature stimulation in the first chamber. Processing may then flow to stage 504.
  • [0064]
    In stage 504, controller 104 suppresses contraction in the one or more portions of heart 102. In one embodiment, processor 306 provides a control signal to signal generator 312 to suppress contraction in heart 102. The control signal may specify specific sites in heart 102 and the type of electrical pulses used to suppress contraction. For example, processor 306 may provide a control signal specifying either right ventricle 112, or left ventricle 114, or both. In addition, processor 306 may specify a pulse type, such as cathodal, anodal, or biphasic, a pulse width, and a pulse amplitude.
  • [0065]
    In response to the control signal from processor 306, signal generator 312 applies one or more electrical pulses to heart 102 via lead 128. For example, signal generator 312 may send electrical pulses via lead 128 to right ventricle electrode 136 and/or left ventricle electrode 140.
  • [0066]
    In stage 506, controller 104 determines whether to continue to suppress contraction in one or more portions of heart 102 based on the electrical activity of heart 102. For example, processor 306 may monitor the electrical activity of heart 102 to determine how heart 102 is responding to the suppression of contraction and determine when to cease suppressing contraction in heart 102.
  • [0067]
    In one embodiment, processor 306 monitors the electrical activity of heart 102 to determine when the electrical activity of a non-suppressed portion of heart 102 reaches a threshold. For example, if controller 104 is suppressing premature contraction in left ventricle 114, then processor may detect when electrical activity in right ventricle 114 reaches a threshold. If the electrical activity of heart 102 has not reached the threshold, then this indicates that one or more portions of heart 102, such as left ventricle 114, still require suppression of contraction and processing repeats again at stage 504. If the electrical activity, for example, in right ventricle 114 reaches the threshold, then processing flows to stage 508.
  • [0068]
    In stage 508, controller 104 ceases the suppression of contraction in the one or more portions of heart 102. In one embodiment, signal generator 312 ceases applying electrical pulses to suppress contraction in response to a control signal from processor 306. The control signal from processor 306 may be generated when the electrical activity in heart 102 exceeds a threshold. In addition, processor 306 may be configured to cease suppressing contraction after a delay period.
  • [0069]
    Furthermore, upon ceasing suppression, processor 306 may allow heart 102 to contract naturally, or provide a control signal to signal generator 312 to subsequently stimulate one or more sites to assist contraction in heart 102. Processing then repeats again at stage 500.
  • [0070]
    Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US479017 *23 Jan 189119 Jul 1892By Mesne assignmentsHanger for electric-arc lamps
US599838 *30 Oct 18971 Mar 1898 Hitching-strap clamp
US3345990 *19 Jun 196410 Oct 1967American Optical CorpHeart-beat pacing apparatus
US3431912 *6 May 196611 Mar 1969Cordis CorpStandby cardiac pacer
US3433228 *6 May 196618 Mar 1969Cordis CorpMultimode cardiac pacer
US3595242 *26 Mar 196927 Jul 1971American Optical CorpAtrial and ventricular demand pacer
US3648707 *16 Jul 196914 Mar 1972Medtronic IncMultimode cardiac paces with p-wave and r-wave sensing means
US3747604 *6 Dec 197124 Jul 1973American Optical CorpAtrial and ventricular demand pacer with separate atrial and ventricular beat detectors
US3814106 *14 Apr 19724 Jun 1974American Optical CorpAtrial and ventricular pacer having independent rate controls and means to maintain a constant av delay
US3903897 *9 Mar 19739 Sep 1975Kent Cambridge Medical LtdCardiac pacer
US3937226 *10 Jul 197410 Feb 1976Medtronic, Inc.Arrhythmia prevention apparatus
US4052991 *25 Sep 197511 Oct 1977Fred ZacoutoMethod of stimulating the heart
US4057067 *6 Apr 19768 Nov 1977Lajos Thomas ZAtrioventricular electrode
US4088140 *18 Jun 19769 May 1978Medtronic, Inc.Demand anti-arrhythmia pacemaker
US4303075 *11 Feb 19801 Dec 1981Mieczyslaw MirowskiMethod and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer
US4312355 *11 Feb 198026 Jan 1982Medtronic B.V.Heart pacemaker
US4332259 *19 Sep 19791 Jun 1982Mccorkle Jr Charles EIntravenous channel cardiac electrode and lead assembly and method
US4335727 *30 May 198022 Jun 1982Mcpherson William EPacemaker assembly having ventricular inhibited and ventricular triggered pacemaker units
US4354497 *23 May 197719 Oct 1982Medtronic, Inc.Cardiac depolarization detection apparatus
US4378020 *20 Aug 198129 Mar 1983Telectronics Pty. Ltd.Dual chamber pacer
US4386610 *27 May 19807 Jun 1983Cordis CorporationVentricular-inhibited cardiac pacer
US4401119 *17 Feb 198130 Aug 1983Medtronic, Inc.Prolongation of timing intervals in response to ectopic heart beats in atrial and ventricular pacemakers
US4418695 *18 Feb 19816 Dec 1983Jacques BuffetImplantable cardiac stimulator having therapeutic diagnostic functions
US4429697 *12 Apr 19827 Feb 1984Telectronics Pty. Ltd.Dual chamber heart pacer with improved ventricular rate control
US4452248 *13 Oct 19815 Jun 1984Keller Jr J WalterBidirectional pacemaker
US4458677 *19 Nov 198110 Jul 1984Mccorkle Jr Charles EIntravenous channel cardiac electrode and lead assembly and method
US4541417 *7 Jun 198217 Sep 1985Krikorian Paul PCoronary augmenter
US4548203 *25 Jun 198422 Oct 1985Purdue Research FoundationSequential-pulse, multiple pathway defibrillation method
US4554922 *30 Sep 198226 Nov 1985Prystowsky Eric NMethod of inhibiting cardiac arrhythmias
US4559946 *18 Jun 198224 Dec 1985Mieczyslaw MirowskiMethod and apparatus for correcting abnormal cardiac activity by low energy shocks
US4561442 *17 Oct 198331 Dec 1985Cordis CorporationImplantable cardiac pacer with discontinuous microprocessor programmable antitachycardia mechanisms and patient data telemetry
US4624260 *7 May 198525 Nov 1986Intermedics, Inc.Pacemaker with conditional atrial tracking capability
US4628934 *7 Aug 198416 Dec 1986Cordis CorporationMethod and means of electrode selection for pacemaker with multielectrode leads
US4641656 *20 Jun 198510 Feb 1987Medtronic, Inc.Cardioversion and defibrillation lead method
US4685446 *21 Feb 198411 Aug 1987Choy Daniel S JMethod for using a ventricular assist device
US4705043 *5 Jul 198510 Nov 1987Mieczslaw MirowskiElectrophysiology study system using implantable cardioverter/pacer
US4712555 *27 Mar 198515 Dec 1987Siemens-Elema AbPhysiologically responsive pacemaker and method of adjusting the pacing interval thereof
US4727877 *12 Aug 19861 Mar 1988Medtronic, Inc.Method and apparatus for low energy endocardial defibrillation
US4774950 *6 Oct 19874 Oct 1988Leonard BloomHemodynamically responsive system for and method of treating a malfunctioning heart
US4799486 *13 Mar 198724 Jan 1989Cardiac Pacemakers, Inc.Refractoriless atrial sensing in dual chamber pacemakers
US4817608 *29 May 19874 Apr 1989Mieczyslaw MirowskiCardioverting transvenous catheter/patch electrode system and method for its use
US4827932 *27 Feb 19879 May 1989Intermedics Inc.Implantable defibrillation electrodes
US4827934 *27 Oct 19879 May 1989Siemens-Pacesetter, Inc.Sensing margin detectors for implantable electromedical devices
US4830006 *17 Jun 198616 May 1989Intermedics, Inc.Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias
US4925443 *27 Feb 198715 May 1990Heilman Marlin SBiocompatible ventricular assist and arrhythmia control device
US4928688 *23 Jan 198929 May 1990Mieczyslaw MirowskiMethod and apparatus for treating hemodynamic disfunction
US4932407 *15 Dec 198812 Jun 1990Medtronic, Inc.Endocardial defibrillation electrode system
US4958632 *5 Mar 198025 Sep 1990Medtronic, Inc.Adaptable, digital computer controlled cardiac pacemaker
US4967749 *18 Aug 19886 Nov 1990Leonard BloomHemodynamically responsive system for and method of treating a malfunctioning heart
US4974588 *26 Mar 19904 Dec 1990Medtronic, Inc.Cardioversion and defibrillation lead system
US4998975 *30 Oct 198912 Mar 1991Siemens-Pacesetter, Inc.Travenously placed defibrillation leads
US5014696 *15 Dec 198814 May 1991Medtronic, Inc.Endocardial defibrillation electrode system
US5024222 *21 Feb 199018 Jun 1991Siemens-Pacesetter, Inc.Hemodynamically rate responsive pacemaker and method of automatically adjusting the escape and A-V intervals
US5083563 *16 Feb 199028 Jan 1992Telectronics Pacing Systems, Inc.Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker
US5111811 *26 Mar 199012 May 1992Medtronic, Inc.Cardioversion and defibrillation lead system with electrode extension into the coronary sinus and great vein
US5129394 *7 Jan 199114 Jul 1992Medtronic, Inc.Method and apparatus for controlling heart rate in proportion to left ventricular pressure
US5158097 *8 Jun 199027 Oct 1992Allegheny-Singer Research InstituteParaneural stimulating lead
US5165403 *26 Feb 199124 Nov 1992Medtronic, Inc.Difibrillation lead system and method of use
US5174289 *7 Sep 199029 Dec 1992Cohen Fred MPacing systems and methods for control of the ventricular activation sequence
US5213098 *26 Jul 199125 May 1993Medtronic, Inc.Post-extrasystolic potentiation stimulation with physiologic sensor feedback
US5251621 *18 Dec 199112 Oct 1993Telectronics Pacing Systems, Inc.Arrhythmia control pacer using skeletal muscle cardiac graft stimulation
US5318593 *18 Nov 19917 Jun 1994Medtronic, Inc.Multi-mode adaptable implantable pacemaker
US5334222 *3 Nov 19922 Aug 1994Cardiac Pacemakers, Inc.Cardiac stimulating apparatus and method for heart failure therapy
US5385579 *30 Mar 199331 Jan 1995Siemens Pacesetter, Inc.Myocardial body implantable lead
US5403356 *28 Apr 19934 Apr 1995Medtronic, Inc.Method and apparatus for prevention of atrial tachy arrhythmias
US5545204 *7 Mar 199413 Aug 1996Cammilli; LeonardoSequential cardiostimulation system (DDD) using a single electrocatheter inserted through the coronary sinus
US5551427 *13 Feb 19953 Sep 1996Altman; Peter A.Implantable device for the effective elimination of cardiac arrhythmogenic sites
US5584868 *27 Jul 199417 Dec 1996Cardiac Pacemakers, Inc.Cardiac stimulating apparatus and method for heart failure therapy
US5626620 *21 Feb 19956 May 1997Medtronic, Inc.Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US5755766 *24 Jan 199726 May 1998Cardiac Pacemakers, Inc.Open-ended intravenous cardiac lead
US5800464 *3 Oct 19961 Sep 1998Medtronic, Inc.System for providing hyperpolarization of cardiac to enhance cardiac function
US5800465 *30 Oct 19961 Sep 1998Medtronic, Inc.System and method for multisite steering of cardiac stimuli
US5814079 *4 Oct 199629 Sep 1998Medtronic, Inc.Cardiac arrhythmia management by application of adnodal stimulation for hyperpolarization of myocardial cells
US5871506 *19 Aug 199616 Feb 1999Mower; Morton M.Augmentation of electrical conduction and contractility by biphasic cardiac pacing
US5899930 *29 Sep 19974 May 1999Cardiac Pacemakers, Inc.Triple port and quadruple port in-line header designs
US5902324 *28 Apr 199811 May 1999Medtronic, Inc.Bi-atrial and/or bi-ventricular sequential cardiac pacing systems
US5919209 *13 May 19966 Jul 1999Medtronic, Inc.System and method for myocardial revalidation and therapy by high rate pacing
US5935160 *24 Jan 199710 Aug 1999Cardiac Pacemakers, Inc.Left ventricular access lead for heart failure pacing
US6067470 *5 Mar 199823 May 2000Mower Family Chf Treatment Irrevocable TrustSystem and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6136019 *16 Jan 199824 Oct 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6141586 *26 May 199831 Oct 2000Mower Family Chf Treatment Irrevocable TrustMethod and apparatus to allow cyclic pacing at an average rate just above the intrinsic heart rate so as to maximize inotropic pacing effects at minimal heart rates
US6141587 *27 May 199831 Oct 2000Mower Family Chf Treatment Irrevocable TrustAugmentation of muscle contractility by biphasic stimulation
US6178351 *11 Jan 199923 Jan 2001The Mower Family Chf Treatment Irrevocable TrustAtrial sensing and multiple site stimulation as intervention means for atrial fibrillation
US6185459 *13 Aug 19996 Feb 2001Medtronic, Inc.Method and apparatus for prevention of atrial tachyarrhythmias
US6295470 *14 Jan 199925 Sep 2001The Mower Family Chf Treatment Irrevocable TrustAntitachycardial pacing
US6298268 *9 Jul 19972 Oct 2001Impulse Dynamics N.V.Cardiac output controller
US6317631 *8 Jan 199713 Nov 2001Impulse Dynamics N.V.Controlling heart performance using a non-excitatory electric field
US6330476 *28 Nov 200011 Dec 2001Impulse Dynamics N.V.Electrical muscle controller using a non-excitatory electric field
US6332096 *16 Feb 200018 Dec 2001Mower Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing
US6337995 *13 Nov 20008 Jan 2002Mower Chf Treatment Irrevocable TrustAtrial sensing and multiple site stimulation as intervention for atrial fibrillation
US6341235 *18 Oct 200022 Jan 2002Mower Chf Treatment Irrevocable TrustAugmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US6343232 *19 Oct 200029 Jan 2002Mower Chf Treatment Irrevocable TrustAugmentation of muscle contractility by biphasic stimulation
US6411845 *5 Sep 200025 Jun 2002Mower Chf Treatment Irrevocable TrustSystem for multiple site biphasic stimulation to revert ventricular arrhythmias
US6463324 *9 Jul 19978 Oct 2002Impulse Dynamics N. V.Cardiac output enhanced pacemaker
US6937895 *14 Aug 200130 Aug 2005Pacesetter, Inc.Multi-site cardiac stimulation device for controlling inter-chamber stimulation delay
USRE38119 *19 Oct 199520 May 2003Mirowski Family Ventures, LLCMethod and apparatus for treating hemodynamic disfunction
Classifications
U.S. Classification607/9
International ClassificationA61N1/362, A61N1/368
Cooperative ClassificationA61N1/368, A61N1/3627
European ClassificationA61N1/368
Legal Events
DateCodeEventDescription
5 Sep 2003ASAssignment
Owner name: MIROWSKI FAMILY VENTURES, L.L.C., DISTRICT OF COLU
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOWER, MORTON M.;REEL/FRAME:014480/0469
Effective date: 20030709